You are viewing an incomplete version of our website. Please click to reload the website as full version.

Aperçu des produits pour anti-FLT4 (FLT4) Anticorps

Full name:
anti-Fms-Related Tyrosine Kinase 4 Anticorps (FLT4)
Chez sont 244 Fms-Related Tyrosine Kinase 4 (FLT4) Anticorps de 35 de différents fournisseurs disponibles. De plus, nous expédions FLT4 Kits (46) et FLT4 Protéines (32) et beaucoup plus de produits pour cette protéine. Un total de 330 FLT4 produits sont actuellement listés.
6130401C07, AI323512, cb1059, Chy, Flk-1, Flk1, Flt-4, FLT41, Krd-1, LMPH1A, Ly73, PCL, sVEGFR-2, VEGFR-2, VEGFR-3, VEGFR2, Vegfr3

Réactivités les plus populaires pour anti-FLT4 (FLT4) Anticorps

Sélectionnez vos espèces et l'application

anti-Mouse (Murine) FLT4 Anticorps:

anti-Human FLT4 Anticorps:

anti-Rat (Rattus) FLT4 Anticorps:

Tous anti-FLT4 Anticorps disponible

Vous arrivez à notre recherche pré-filtrée.

anti-FLT4 Anticorps mieux référencés

  1. Human Monoclonal FLT4 Primary Antibody pour FACS - ABIN4896919 : Shawber, Funahashi, Francisco, Vorontchikhina, Kitamura, Stowell, Borisenko, Feirt, Podgrabinska, Shiraishi, Chawengsaksophak, Rossant, Accili, Skobe, Kitajewski: Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. dans The Journal of clinical investigation 2007 (PubMed)
    Show all 5 references for ABIN4896919

  2. Human Monoclonal FLT4 Primary Antibody pour FACS - ABIN4896918 : Roorda, Ter Elst, Scherpen, Meeuwsen-de Boer, Kamps, de Bont: VEGF-A promotes lymphoma tumour growth by activation of STAT proteins and inhibition of p27(KIP1) via paracrine mechanisms. dans European journal of cancer (Oxford, England : 1990) 2010 (PubMed)
    Show all 5 references for ABIN4896918

  3. Human Monoclonal FLT4 Primary Antibody pour ELISA, WB - ABIN969147 : Goodyear, Kheyfets, Garcia, Stearns: Role of the VEGFR3/VEGFD receptor axis in TGFbeta1 activation of primary prostate cell lines. dans The Prostate 2009 (PubMed)
    Show all 3 references for ABIN969147

  4. Human Polyclonal FLT4 Primary Antibody pour WB - ABIN616061 : Paone, Galli, Gabellini, Lukashev, Starace, Gorlach, De Cesaris, Ziparo, Del Bufalo, Sitkovsky, Filippini, Riccioli: Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alpha. dans Neoplasia (New York, N.Y.) 2010 (PubMed)
    Show all 3 references for ABIN616061

  5. Human Polyclonal FLT4 Primary Antibody pour IHC (fro), IHC (p) - ABIN115449 : Earnshaw, Halligan, Cooke, Heck, Liu: Topoisomerase II is a structural component of mitotic chromosome scaffolds. dans The Journal of cell biology 1985 (PubMed)
    Show all 2 references for ABIN115449

  6. Human Monoclonal FLT4 Primary Antibody pour EIA, IHC (fro) - ABIN115161 : Davids, Davids, Charlton, Ng, Chong, Laubscher, Dar, Hodge, Soong, Goh: Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma. dans Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 (PubMed)
    Show all 2 references for ABIN115161

  7. Human Monoclonal FLT4 Primary Antibody pour EIA, WB - ABIN115160 : Jussila, Valtola, Partanen, Salven, Heikkilä, Matikainen, Renkonen, Kaipainen, Detmar, Tschachler, Alitalo, Alitalo: Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. dans Cancer research 1998 (PubMed)
    Show all 2 references for ABIN115160

  8. Human Polyclonal FLT4 Primary Antibody pour IHC (p) - ABIN115450 : Dietrich, Onderka, Bock, Kruse, Vossmeyer, Stragies, Zahn, Cursiefen: Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade. dans The American journal of pathology 2007 (PubMed)

  9. Mouse (Murine) Polyclonal FLT4 Primary Antibody pour FACS - ABIN4896915 : Imoukhuede, Popel: Expression of VEGF receptors on endothelial cells in mouse skeletal muscle. dans PLoS ONE 2012 (PubMed)

Plus d’anticorps contre FLT4 partenaires d’interaction

Mouse (Murine) Fms-Related Tyrosine Kinase 4 (FLT4) interaction partners

  1. Intronic Flk1 (Montrer KDR Anticorps) genetic enhancer element directs arterial-specific expression via RBPJ (Montrer RBPJ Anticorps)-mediated venous repression.

  2. Endothelial SCUBE2 may be a novel coreceptor for VEGFR2 and potentiate VEGF-induced signaling in adult angiogenesis.

  3. VEGFR2 (Montrer KDR Anticorps) signaling is necessary to maintain the integrity of the intestinal mucosal microvasculature during the postnatal period and lack of VEGFR2 (Montrer KDR Anticorps) signaling predisposes to NEC in neonatal mice.

  4. First-in-class selective PET tracers for imaging VEGFR-1 (Montrer FLT1 Anticorps) and VEGFR-2 (Montrer KDR Anticorps) were constructed and successfully validated in an orthotopic murine tumor model.

  5. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.

  6. Vegf-d (Montrer Figf Anticorps) and its receptor Vegfr-3 were more highly expressed in lungs of hyperoxic, versus normoxic, wild-type mice, indicating that components of the Vegf-d (Montrer Figf Anticorps) signalling pathway are up-regulated in hyperoxia.

  7. data for the first time demonstrate a calpain/PTP1B/VEGFR2 negative feedback loop in the regulation of VEGF-induced angiogenesis. Modulation of local PTP1B and/or calpain activities may prove beneficial in the treatment of impaired wound healing in diabetes.

  8. We found that bevacizumab reduced airway hyper-responsiveness (AHR (Montrer AHR Anticorps)) and airway inflammation induced by HDM (Montrer HDAC3 Anticorps). In addition, HDM (Montrer HDAC3 Anticorps) exposure promoted expression of VEGF (Montrer VEGFA Anticorps), and caused AHR (Montrer AHR Anticorps), disruptions of the epithelial barrier, and airway inflammation. Bevacizumab ameliorated AHR (Montrer AHR Anticorps) and the release of Th2 cytokines, thereby protecting the epithelial barrier. Our data suggest that bevacizumab may be a new therapeutic strategy for asthm

  9. Introduction of sVEGFR-2 suppressed lymphangiogenesis in primary lung cancer and also suppressed lymphogenic metastasis by inhibiting VEGF-C (Montrer VEGFC Anticorps), followed by down-regulation of VEGFR-2 (Montrer KDR Anticorps), VEGFR-3 and MMPs.

  10. VEGFB (Montrer VEGFB Anticorps)-Induced Vascular Remodeling in Adipose Tissue Requires VEGF (Montrer VEGFA Anticorps)/VEGFR2 (Montrer KDR Anticorps). VEGFB (Montrer VEGFB Anticorps)-Induced Vascular Remodeling Improves Insulin (Montrer INS Anticorps) Supply, Signaling, and Function in Obese Mice.

Human Fms-Related Tyrosine Kinase 4 (FLT4) interaction partners

  1. These results indicate that VEGF-C (Montrer VEGFC Anticorps)-induced MSC (Montrer MSC Anticorps) osteogenesis is mediated through VEGFR2 (Montrer KDR Anticorps) and VEGFR3, and followed the activation of the ERK (Montrer EPHB2 Anticorps)/RUNX2 (Montrer RUNX2 Anticorps) signaling pathway.

  2. Assessment of VEGFR-2/VEGFR (Montrer KDR Anticorps)-3 on tumor samples might serve as a putative prognostic factor in renal cell carcinoma (Montrer MOK Anticorps) cases, identifying a subset of patients that may benefit from antiangiogenic treatments targeting VEGFR (Montrer KDR Anticorps) receptors.

  3. This study suggests that NRP1 (Montrer NELL1 Anticorps) expression and LVD are independent factors that are likely to predict the risk of LN metastasis in squamous cell carcinoma (SCC (Montrer CYP11A1 Anticorps))of the tongue, whereas the expression of VEGFC (Montrer VEGFC Anticorps), VEGFR3, CCR7 (Montrer CCR7 Anticorps), and SEMA3E (Montrer SEMA3E Anticorps) are nonindependent predictive factors

  4. Data indicate that vascular endothelial growth factor D (VEGF-D (Montrer Figf Anticorps)) was the best indicator of metastasis and vascular endothelial growth factors and receptor-3 (VEGFR-3) may help to determine the prognosis and management of colorectal cancer (CRC (Montrer CALR Anticorps)).

  5. The summarizes the structure and function features of pathway-related molecules of VEGFC (Montrer VEGFC Anticorps)/D-VEGFR3/NRP2 (Montrer NELL2 Anticorps) axis, stages of various tumors and their molecular mechanisms and significances in tuthe expression changes of these molecules in different anatomic organs or histopathologic types or development lymphatic metastasis.

  6. The most extensively accepted signaling pathways promoting lymphangiogenesis in tumors include the secreted lymphangiogenic proteins: VEGF-C (Montrer VEGFC Anticorps) and VEGF-D (Montrer Figf Anticorps), and their cognate receptor on lymphatic endothelium VEGF receptor (Montrer FLT1 Anticorps)-3 (VEGFR-3).

  7. MTA1 (Montrer MTA1 Anticorps) is up-regulated in CRC (Montrer CALR Anticorps); its expression is inversely associated with lymphatic metastases and the expression of VEGFC (Montrer VEGFC Anticorps), VEGFD (Montrer Figf Anticorps) and VEGFR3

  8. this study uncovers a unique molecular mechanism of lymphangiogenesis in which galectin-8 (Montrer LGALS8 Anticorps)-dependent crosstalk among VEGF-C (Montrer VEGFC Anticorps), podoplanin (Montrer PDPN Anticorps) and integrin pathways plays a key role.

  9. Report FLT4 genetic alterations in angiosarcomas.

  10. High expression levels of VEGFR1 (Montrer FLT1 Anticorps) and VEGFR3 were associated with a higher rate of lung metastasis.

Zebrafish Fms-Related Tyrosine Kinase 4 (FLT4) interaction partners

  1. miR (Montrer MYLIP Anticorps)-126a directs lymphatic endothelial cell sprouting and extension by interacting with Cxcl12a-mediated chemokine (Montrer CCL1 Anticorps) signaling and Vegfc (Montrer VEGFC Anticorps)-Flt4 signal axis.

  2. Ca(2 (Montrer CA2 Anticorps)+) oscillations depended upon VEGF receptor-2 (Vegfr2) and Vegfr3 in endothelial cells budding from the dorsal aorta (DA) and posterior cardinal (Montrer CARD8 Anticorps) vein, respectively.

  3. Experiments in mice and zebrafish demonstrate that changing levels of VEGFR3/Flt4 modulates aortic lumen diameter consistent with flow-dependent remodeling

  4. In the embryo, phenotypes driven by increased Vegfc (Montrer VEGFC Anticorps) are suppressed in the absence of Ccbe1 (Montrer CCBE1 Anticorps), and Vegfc (Montrer VEGFC Anticorps)-driven sprouting is enhanced by local Ccbe1 (Montrer CCBE1 Anticorps) overexpression. Moreover, Vegfc (Montrer VEGFC Anticorps)- and Vegfr3-dependent Erk (Montrer MAPK1 Anticorps) signaling is impaired in the absence of Ccbe1 (Montrer CCBE1 Anticorps).

  5. Flt4 plays an essential role in lymphangiogenesis [review]

  6. The parallel growth of motoneuron axons with the dorsal aorta depends on Vegfc (Montrer VEGFC Anticorps)/Vegfr3 signaling in zebrafish.

  7. Rspo1-Wnt-VegfC-Vegfr3 signaling plays a crucial role as an endothelial-autonomous permissive cue for developmental angiogenesis.

  8. flt4 signalling is suppressed by Dll4 (Montrer DLL4 Anticorps) in developing zebrafish intersegmental arteries.

FLT4 profil antigène

Antigen Summary

This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA.

Alternative names and synonyms associated with FLT4

  • FMS-like tyrosine kinase 4 (Flt4) anticorps
  • fms-related tyrosine kinase 4 (FLT4) anticorps
  • fms-related tyrosine kinase 4 (Flt4) anticorps
  • fms-related tyrosine kinase 4 (flt4) anticorps
  • kinase insert domain protein receptor (Kdr) anticorps
  • 6130401C07 anticorps
  • AI323512 anticorps
  • cb1059 anticorps
  • Chy anticorps
  • Flk-1 anticorps
  • Flk1 anticorps
  • Flt-4 anticorps
  • FLT41 anticorps
  • Krd-1 anticorps
  • LMPH1A anticorps
  • Ly73 anticorps
  • PCL anticorps
  • sVEGFR-2 anticorps
  • VEGFR-2 anticorps
  • VEGFR-3 anticorps
  • VEGFR2 anticorps
  • Vegfr3 anticorps

Protein level used designations for FLT4

chylous ascites , receptor protein tyrosine kinase , tyrosine-protein kinase receptor FLT4 , vascular endothelial growth factor receptor 3 , vascular endothelial growth factor receptor-3 , FLT-4 , VEGFR-3 , fms-like tyrosine kinase 4 , soluble VEGFR3 variant 1 , soluble VEGFR3 variant 2 , soluble VEGFR3 variant 3 , FMS-like tyrosine kinase 4 , tyrosine kinase VEGFR-3 , VEGFR3 , expando , receptor tyrosine kinase Flt4 , VEGF receptor-2 , fetal liver kinase 1 , kinase NYK , protein-tyrosine kinase receptor flk-1 , soluble vascular endothelial growth factor receptor 2 , vascular endothelial growth factor receptor 2 , vascular endothelial growth factor receptor- 2 , vascular endothelial growth factor receptor-2

14257 Mus musculus
2324 Homo sapiens
114110 Rattus norvegicus
338031 Bos taurus
100008829 Oryctolagus cuniculus
395742 Gallus gallus
30121 Danio rerio
16542 Mus musculus
Fournisseurs de qualité sélectionnés pour anti-FLT4 (FLT4) Anticorps
Avez-vous cherché autre chose?